Schwerin, Stefan https://orcid.org/0009-0005-6307-3156
Dragovic, Srdjan Z. https://orcid.org/0000-0002-2413-2361
Ostertag, Julian https://orcid.org/0009-0006-9928-8041
Nguyen, Duy-Minh
Schneider, Gerhard https://orcid.org/0000-0002-4903-0118
Kreuzer, Matthias https://orcid.org/0000-0003-2472-3556
Funding for this research was provided by:
Technische Universität München
Article History
Received: 2 February 2025
Accepted: 5 April 2025
First Online: 21 April 2025
Change Date: 31 August 2025
Change Type: Update
Change Details: The original online version of this article was revised, the figure caption format.
Change Date: 5 September 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10877-025-01354-3
Declarations
:
: The Scientific and Ethics Committee of the AHEPA University Hospital, Aristotle University of Thessaloniki approved the study under protocol number 142/12-04-2023 [ ].
: All human subjects provided written informed consent, as stated in the pertinent data descriptor [ ].
: Matthias Kreuzer is named as an inventor for a patent dealing with spectral EEG features and age (U.S. Provisional Patent Application No. 62/914,183). Gerhard Schneider and Matthias Kreuzer are named as inventors for a patent filed on a novel method for intraoperative EEG monitoring (U.S. Patent Application Serial No. 62/960,947). Gerhard Schneider and Matthias Kreuzer are also named as inventors for a patent dealing with the EEG features during anesthesia emergence (U.S. Provisional Patent Application No. 63/459,294). Additionally, Matthias Kreuzer received funding from Masimo Corporation, Narcotrend-Gruppe, Medtronic GmbH, and Fresenius Kabi Deutschland GmbH for conducting EEG-based training for anesthesiologists. Srdjan Dragovic is named as inventor for provisional patents of EEG predictors of low risk for delirium during anesthesia emergence (U.S. Patent Application No. 63/397,667 and U.S. Patent Application No. 63/459,294). Stefan Schwerin, Julian Ostertag, and Duy-Minh Nguyen declare no competing interests.